These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3894280)

  • 1. Sequential studies on the role of mitoxantrone in the treatment of acute leukemia.
    Prentice HG; Wimperis JZ; Robbins G
    Invest New Drugs; 1985; 3(2):207-12. PubMed ID: 3894280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mitozantrone in the treatment of acute leukaemia.
    Prentice HG
    Acta Haematol; 1987; 78 Suppl 1():136-8. PubMed ID: 3124436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Moore JO; Olsen GA
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Meyer P; Ho AD; Ehninger G; Mjaaland I; Heidemann E; Seither E
    Invest New Drugs; 1985; 3(2):203-6. PubMed ID: 3860490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I-II trial of mitoxantrone in acute leukemia: an interim report.
    Arlin ZA; Dukart G; Schoch I; Reisman A; Moore J; Silver RA; Cassileth P; Bertino J; Gams R
    Invest New Drugs; 1985; 3(2):213-7. PubMed ID: 3860491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Ehninger G; Ho AD; Meyer P; Mjaaland I; Ostendorf P; Seither E
    Onkologie; 1985 Jun; 8(3):146-8. PubMed ID: 3895096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II trial of mitoxantrone in acute leukemia.
    Arlin ZA; Silver R; Cassileth P; Armentrout S; Gams R; Daghestani A; Coleman M; Schoch I; Dukart G
    Cancer Treat Rep; 1985 Jan; 69(1):61-4. PubMed ID: 3855386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone in refractory acute leukemia in children: a phase I study.
    Starling KA; Mulne AF; Vats TS; Schoch I; Dukart G
    Invest New Drugs; 1985; 3(2):191-5. PubMed ID: 4019122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone in relapsed and refractory acute leukemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):32-5. PubMed ID: 6385263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia.
    Paciucci PA; Dutcher JP; Cuttner J; Strauman JJ; Wiernik PH; Holland JF
    Leukemia; 1987 Jul; 1(7):565-7. PubMed ID: 3478540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia.
    Ozkaynak MF; Avramis VI; Carcich S; Ortega JA
    Med Pediatr Oncol; 1998 Dec; 31(6):475-82. PubMed ID: 9835899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential intermediate-dose cytosine arabinoside and mitoxantrone for patients with relapsed and refractory acute myelocytic leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Am J Hematol; 1990 Sep; 35(1):22-5. PubMed ID: 2202204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
    Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of mitoxantrone in acute leukemia.
    Masaoka T; Shibata H; Oguma S; Nagai K; Kitani T; Horiuchi A; Yasunaga K; Yonezawa T; Kawagoe H
    Invest New Drugs; 1985; 3(2):197-201. PubMed ID: 3860489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose mitoxantrone in acute leukaemia: New York Medical College experience.
    Feldman EJ
    Eur J Cancer Care (Engl); 1997 Dec; 6(4 Suppl):27-32. PubMed ID: 9460340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone in patients with acute leukemia in relapse.
    Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
    Cancer Res; 1983 Aug; 43(8):3919-22. PubMed ID: 6861154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of mitoxantrone in head and neck cancer.
    Aapro MS; Alberts DS
    Invest New Drugs; 1984; 2(3):329-30. PubMed ID: 6511239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.